Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization

Table 13

Determination of drug contents by different methods.

Formulation	Dispersion time (sec.)	Drug content (%) by dilution method		Drug content (%) by Petri dish method
		Levocetrizine dihydrochloride	Montelukast	Levocetrizine dihydrochloride	Montelukast
K1	31.41 ± 0.41	94.65 ± 1.08	93.53 ± 1.15	96.02 ± 1.26	95.14 ± 1.14
K2	30.15 ± 0.53	96.38 ± 1.13	94.17 ± 1.06	95.28 ± 1.23	93.04 ± 1.19
K3	26.32 ± 0.64	96.68 ± 1.05	93.88 ± 0.98	97.41 ± 1.19	94 .53 ± 1.26
K4	19.79 ± 0.59	98.14 ± 0.97	95.63 ± 0.92	98.74 ± 1.16	95.78 ± 1.16
K5	22.62 ± 0.47	97.46 ± 1.16	94.05 ± 1.02	98.10 ± 1.24	93.92 ± 1.28
K6	24.58 ± 0.68	98.22 ± 1.14	92.98 ± 1.13	96.68 ± 1.18	95.11 ± 1.17